Contract: $2,651,229 - Department of Health and Human Services - Jul. 1, 2009
0% voted satisfied - 100% voted not satisfied - 5 vote(s) cast
Award Description: The overall purpose of the ARRA funds received by Merck is to provide the CDC Project grantees vaccines for their respective Immunization Programs. In some instances, the ARRA funds will provide vaccines that would cover a budget shortfall in the program; in other instances, the ARRA funds will allow an expansion of services offered. Each grantee will determine the most appropriate use for said funding. Merck will deliver the vaccines in accordance with the CDC contracts under which the Projects currently order and access vaccines.
Project Description: GARDASIL® - 7000 doses invoiced M-M-R® II - 6000 doses invoiced RECOMBIVAX HB® - 2300 doses invoiced ROTATEQ® - 900 doses invoiced VAQTA®- 29800 doses invoiced VARIVAX® - 80 doses invoiced
Jobs Summary: N/A (Total jobs reported: 0)
Project Status: Less Than 50% Completed
This award's data was last updated on Jul. 1, 2009. Help expand these official descriptions using the wiki below.
Funds from this award have been disbursed to subcontractors. Click here to see a list of subcontractors.
|Fisher Scientific Company LLC||$79,596||PITTSBURGH||PA|
|Hyclone Laboratories, Inc.||$61,362||LOGAN||UT|